期刊文献+

人脐带间充质干细胞不同输注途径对急性肾小管坏死的影响 被引量:7

Influence of different infusion methods of human umbilical cord mesenchymal stem cells on acute tubular necrosis
暂未订购
导出
摘要 背景:研究已证实外源性间充质干细胞能够迁移、定居于缺血再灌注损伤后的肾组织中分化为肾小管上皮细胞,恢复肾脏组织结构和功能。目前对以动脉注射或静脉注射途径移植干细胞哪种更好仍存在争议。目的:观察人脐带间充质干细胞经不同途径移植对家犬急性肾小管坏死的影响。方法:建立健康家犬急性肾小管坏死模型,以随机编号法分为2组,分别以外周静脉注射及右股动脉介入经肾动脉直接注射DAPI标记的人脐带间充质干细胞。移植后24h,光镜下观察肾组织形态改变,荧光显微镜下观察人脐带间充质干细胞植入实验动物体内后的存活情况。结果与结论:普通光镜下观察可见两组动物肾小管上皮细胞均出现广泛肿胀、变性、坏死等病理变化。经外周静脉注射及经肾动脉直接注射的人脐带间充质干细胞均在病损肾脏中成活,且两组荧光强度差异无显著性意义(P>0.05)。说明两种途径移植人脐带间充质干细胞均可在肾脏内定殖,修复肾脏组织结构的效果相当,相对于动脉注射途径,经静脉注射移植途径创伤较小。 BACKGROUND:Studies have confirmed that exogenous mesenchymal stem cells can migrate and establish in the nephridial tissue following ischemia/reperfusion injury,differentiate into renal tubular epithelial cells,and recover structure and function of thekidney.At present,it is controversial which is better,arterial injection or intravenous injection,for transplanting stem cells.OBJECTIVE:To observe the effects of different transplantation methods of human umbilical cord mesenchymal stem cells on dogs with acute tubular necrosis(ATN).METHODS:Healthy dog models of ATN were established and randomly divided into two groups.Human umbilical cord derived mesenchymal stem cells were labeled with DAPI.Then the cells were injected through peripheral veins and right femoral artery into model dogs' body.24 hours later,histological changes were observed by light microscope,and the survival of human umbilicalcord mesenchymal stem cells was evaluated by fluorescent microscope.RESULTS AND CONCLUSION:Under common optical microscope,pathological changes such as swelling,degeneration and necrosis appeared in renal tubular epithelial cells in both groups.The injected human umbilical cord mesenchymal stem cells couldsurvive in the affected kidney.There was no significant difference on fluorescence intensity between two groups(P 0.05).Theseindicated that transplanted human umbilical cord mesenchymal stem cells by two pathways can survive in the kidneys.The outcomes were similar in repairing the kidney.Compared with arterial injection,the transplantation of intravenous injection obtained little trauma.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2010年第40期7470-7473,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
  • 相关文献

参考文献7

二级参考文献82

  • 1廖晓星,唐洪林,孙庭,侯垒,崔功静.肾小管上皮细胞原代培养及鉴定[J].中国现代医药杂志,2004,6(5):12-14. 被引量:6
  • 2张杰,单清,马萍,姜严明,陈鹏,温静霞,周游,钱焕文,裴雪涛.骨髓间充质干细胞在激光损伤大鼠视网膜下分化的观察[J].中华医学杂志,2003,83(22):1993-1998. 被引量:13
  • 3Herzog EL, Chai L, Krause DS, et al. Plasticity of marrow-derived stem cells. B lood. 2003.102 : 3483-3493.
  • 4Kale S, Karihsloo A, Clark PR, et al. Bone marrow stem cells contribute to repair of the ischemically injured renal tubule. J Clin Invest ,2003,112:42-49.
  • 5David LS. Stem cells in regenerative biology and medicine. Wound Repair and Regeneration,2001,9:429-441.
  • 6Poulsom R, Forbes SJ, Hodivala-Dilke K, et al. Bone marrow contributes to renal parenchymal turnover and regeneration. J Pathol, 2001,195 : 229-235.
  • 7Rookmaaker MB, Smits AM, Tolboom H, et al. Bone-marrow-derived cells contribute to glomerular endothelial repair in experimental glomerulonephritis. Am J Pathol,2003 ,163 :553-562.
  • 8Rao MS,Mattson MP.Stem cells and aging:expanding the possibilities[J].Mech Ageing Dev,2001,122(6):713-734.
  • 9Yuri A,Roman OV,Veronika A,et al.Serarching for alternative sources of postnatal human mesenchymal stem cells:Candidate MSC-like cells from umbilical cord[J].Stem Cells,2003,21(1):105-110.
  • 10Covas DT,Siufi JL,Silva AR,et al.Isolation and culture of umbilical vein mesenchymal stem cells[J].Braz J Med Biol Res,2003,36(11):1179-1183.

共引文献73

同被引文献91

  • 1程芮,王士雯,张友荣,孟玲,曹丰,徐勇,王韫芳,裴雪涛.3种不同途径移植自体骨髓间充质干细胞治疗急性心肌梗死效果比较[J].中华实验外科杂志,2005,22(12):1504-1506. 被引量:19
  • 2颜小华,陈晓.脐血间充质干细胞静脉移植治疗新生大鼠缺氧缺血性脑损伤[J].中国新生儿科杂志,2006,21(3):158-161. 被引量:11
  • 3谢院生,陈香美.急性肾小管坏死后的修复与再生[J].中华肾脏病杂志,2006,22(11):658-660. 被引量:17
  • 4Spaeth E, Klopp A, Dembinski J, et al. Inflammation and tumor mi-croenvironments :defining the migratory itinerary of mesenchymalstem cells[J]. Gene Ther, 2008, 15(10):730-738.
  • 5Yuan L, Wu MJ, Sun HY, et al. VEGF-modified human embryonicmesenchymal stem cell implantation enhances protection againstcisplatin-induced acute kidney injury[J]. Am J Physiol Renal Physi-ol’2011’300(l):F207-218.
  • 6Choi S,Park M, Kim J, et al. The role of mesenchymal stem cells inthe functional improvement of chronic renal failure[J]. Stem CellsDev, 2009,18(3):521-529.
  • 7Semedo P, Correa-Costa M, Antonio Cenedeze M, et al. Mesenchy-mal stem cells attenuate renal fibrosis through immune modulationand remodeling properties in a rat remnant kidney model[J]. StemCells, 2009,27(12):3063-3073.
  • 8Cavaglieri RC, Martini D, Sogayar MC, et al. Mesenchymal stemcells delivered at the subcapsule of the kidney ameliorate renal dis-ease in the rat remnant kidney model[J]. Transplant Proc, 2009,41(3):947-951.
  • 9Zonta S, De Martino M, Bedino G, et al. Which is the most suitableand effective route of administration for mesenchymal stem cell-based immunomodulation therapy in experimental kidney transplan-tation: endovenous or arterial[J]? Transplant Proc,2010, 42(4):1336-1340.
  • 10Yoo JH, Park C, Jung DI, et al. In vivo cell tracking of canine allo-genic mesenchymal stem cells administration via renal arterial cath-eterization and physiopathological effects on the kidney in twohealthy dogs[J]. J Vet Med Sci, 2011,73(2):269-274.

引证文献7

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部